BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 22768249)

  • 1. Ectopic expression of MiR-125a inhibits the proliferation and metastasis of hepatocellular carcinoma by targeting MMP11 and VEGF.
    Bi Q; Tang S; Xia L; Du R; Fan R; Gao L; Jin J; Liang S; Chen Z; Xu G; Nie Y; Wu K; Liu J; Shi Y; Ding J; Fan D
    PLoS One; 2012; 7(6):e40169. PubMed ID: 22768249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-125a-3p suppresses the growth and progression of papillary thyroid carcinoma cell by targeting MMP11.
    Song M; Wang N; Li Z; Zhang Y; Zheng Y; Yi P; Chen J
    J Cell Biochem; 2020 Feb; 121(2):984-995. PubMed ID: 31489990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-7 downregulates the oncogene VDAC1 to influence hepatocellular carcinoma proliferation and metastasis.
    Wang F; Qiang Y; Zhu L; Jiang Y; Wang Y; Shao X; Yin L; Chen J; Chen Z
    Tumour Biol; 2016 Aug; 37(8):10235-46. PubMed ID: 26831666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-370 Regulates Cellepithelial-Mesenchymal Transition, Migration, Invasion, and Prognosis of Hepatocellular Carcinoma by Targeting GUCD1.
    He Y; He X
    Yonsei Med J; 2019 Mar; 60(3):267-276. PubMed ID: 30799589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-383 inhibits hepatocellular carcinoma cell proliferation via targeting APRIL.
    Chen L; Guan H; Gu C; Cao Y; Shao J; Wang F
    Tumour Biol; 2016 Feb; 37(2):2497-507. PubMed ID: 26385772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-34a and miR-125a-5p inhibit proliferation and metastasis but induce apoptosis in hepatocellular carcinoma cells via repressing the MACC1-mediated PI3K/AKT/mTOR pathway.
    Zhang YM; Wu QM; Chang LY; Liu JC
    Neoplasma; 2020 Sep; 67(5):1042-1053. PubMed ID: 32484698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-877-5p suppresses cell growth, migration and invasion by targeting cyclin dependent kinase 14 and predicts prognosis in hepatocellular carcinoma.
    Yan TH; Qiu C; Sun J; Li WH
    Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3038-3046. PubMed ID: 29863248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-663a inhibits tumor growth and invasion by regulating TGF-β1 in hepatocellular carcinoma.
    Zhang C; Chen B; Jiao A; Li F; Sun N; Zhang G; Zhang J
    BMC Cancer; 2018 Nov; 18(1):1179. PubMed ID: 30486878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-125a-5p inhibits tumorigenesis in hepatocellular carcinoma.
    Xu X; Tao Y; Niu Y; Wang Z; Zhang C; Yu Y; Ma L
    Aging (Albany NY); 2019 Sep; 11(18):7639-7662. PubMed ID: 31527306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. microRNA-146a inhibits cancer metastasis by downregulating VEGF through dual pathways in hepatocellular carcinoma.
    Zhang Z; Zhang Y; Sun XX; Ma X; Chen ZN
    Mol Cancer; 2015 Jan; 14():5. PubMed ID: 25608619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-126-3p suppresses tumor metastasis and angiogenesis of hepatocellular carcinoma by targeting LRP6 and PIK3R2.
    Du C; Lv Z; Cao L; Ding C; Gyabaah OA; Xie H; Zhou L; Wu J; Zheng S
    J Transl Med; 2014 Sep; 12():259. PubMed ID: 25240815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lowered expression of microRNA-125a-5p in human hepatocellular carcinoma and up-regulation of its oncogenic targets sirtuin-7, matrix metalloproteinase-11, and c-Raf.
    Coppola N; de Stefano G; Panella M; Onorato L; Iodice V; Minichini C; Mosca N; Desiato L; Farella N; Starace M; Liorre G; Potenza N; Sagnelli E; Russo A
    Oncotarget; 2017 Apr; 8(15):25289-25299. PubMed ID: 28445974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29.
    Du H; Xu Q; Xiao S; Wu Z; Gong J; Liu C; Ren G; Wu H
    Life Sci; 2019 May; 224():1-11. PubMed ID: 30876939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-1307-3p promotes tumor growth and metastasis of hepatocellular carcinoma by repressing DAB2 interacting protein.
    Chen S; Wang L; Yao B; Liu Q; Guo C
    Biomed Pharmacother; 2019 Sep; 117():109055. PubMed ID: 31176165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of miRNA-638 promotes angiogenesis and growth of hepatocellular carcinoma by targeting VEGF.
    Cheng J; Chen Y; Zhao P; Liu X; Dong J; Li J; Huang C; Wu R; Lv Y
    Oncotarget; 2016 May; 7(21):30702-11. PubMed ID: 27120793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of microRNA-100 correlates with tumor progression and poor prognosis in hepatocellular carcinoma.
    Chen P; Zhao X; Ma L
    Mol Cell Biochem; 2013 Nov; 383(1-2):49-58. PubMed ID: 23842624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-98-5p Inhibits Tumorigenesis of Hepatitis B Virus-Related Hepatocellular Carcinoma by Targeting NF-κB-Inducing Kinase.
    Fei X; Zhang P; Pan Y; Liu Y
    Yonsei Med J; 2020 Jun; 61(6):460-470. PubMed ID: 32469170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-6875-3p promotes the proliferation, invasion and metastasis of hepatocellular carcinoma via BTG2/FAK/Akt pathway.
    Xie Y; Du J; Liu Z; Zhang D; Yao X; Yang Y
    J Exp Clin Cancer Res; 2019 Jan; 38(1):7. PubMed ID: 30621734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-497 targets VEGF signal pathway to regulate proliferation, invasion and migration of hepatocellular carcinoma cells: a primary study using DEC-MRI.
    Zhang T; Ding G; Wang H; Hu H; Wang Y; Li H; Zhang H; Wang L; Lin W; Hao L; Li B; Zheng C; Du Y; Song L
    J BUON; 2021; 26(2):418-428. PubMed ID: 34076988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Astemizole promotes the anti-tumor effect of vitamin D through inhibiting miR-125a-5p-meidated regulation of VDR in HCC.
    Xu J; Wang Y; Zhang Y; Dang S; He S
    Biomed Pharmacother; 2018 Nov; 107():1682-1691. PubMed ID: 30257386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.